Literature DB >> 8116074

Neoplasms of unknown primary site: a clinicopathological study of autopsied patients.

J I Mayordomo1, J M Guerra, C Guijarro, M D García-Prats, A Gómez, M López-Brea, R González, P Hergueta, M A López-Pino, F Martínez-Tello.   

Abstract

BACKGROUND: Malignant neoplasms of an unknown primary site (NUPS) remain a diagnostic and therapeutic challenge in clinical practice. With this in mind, we have reviewed all autopsies performed in patients with NUPS in a single institution. PATIENTS AND METHODS: By reviewing 1656 autopsies performed on adults in our institution (1974-1990), 43 cases of NUPS were found. (NUPS was defined as histologically proven malignant tumor for which a primary site could not be found after anamnesis, complete physical examination, chest X-ray and routine chemistries.)
RESULTS: There were 24 men (56%) and 19 women. Mean age was 62 years (76% of patients were aged 40-75). Clinical presentation included general deterioration (73%), digestive symptoms (58%), liver enlargement (58%) abdominal pain (56%), respiratory symptoms (45%), ascites (26%) and node enlargement (16%). Abnormalities in analysis and image tests were frequent but nonspecific. Median time from admission to death was 42 days (range, 4-135). Pathologic diagnoses at autopsy were: 23 adenocarcinomas (53%), arising from pancreas (6), biliary tree (6), lung (3), prostate (2), stomach (1), kidney (1) and unknown (4); 3 squamous carcinomas (5%) (1 renal pelvis, 1 biliary tree, 1 stomach); 5 undifferentiated carcinomas (1 lung, 4 unknown); and 12 miscellaneous tumors (including 3 lymphomas, 3 neuroendocrine tumors, 3 hepatocarcinomas, 2 mesotheliomas and 1 melanoma). There was a tendency towards a metastatic pattern different from that expected from the primary tumor. Image tests were of little usefulness in the search for the primary tumor.
CONCLUSIONS: 1) Adenocarcinomas were the most frequent tumor presenting as NUPS, especially from the pancreas and biliary tree. 2) In this series, at least 11% of patients were amenable to standard systemic therapies (3 lymphomas and 2 prostatic adenocarcinomas) if a correct pathologic diagnosis could have been established when alive. 3) Presenting symptoms and metastatic pattern differed from those expected for the primary neoplasm eventually found. 4) Image tests were often misleading as regards the primary site, although they were useful to quantify the dissemination of the tumor.

Entities:  

Mesh:

Year:  1993        PMID: 8116074     DOI: 10.1177/030089169307900507

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  14 in total

Review 1.  Tumor Dormancy and Relapse: From a Natural Byproduct of Evolution to a Disease State.

Authors:  Masoud H Manjili
Journal:  Cancer Res       Date:  2017-05-15       Impact factor: 12.701

Review 2.  Carcinomas of an unknown primary origin--diagnosis and treatment.

Authors:  Christophe Massard; Yohann Loriot; Karim Fizazi
Journal:  Nat Rev Clin Oncol       Date:  2011-11-01       Impact factor: 66.675

3.  Review of primary unknown cancer: cases referred to the National Cancer Center Hospital East.

Authors:  Nobuaki Matsubara; Hirofumi Mukai; Shunji Nagai; Kuniaki Itoh
Journal:  Int J Clin Oncol       Date:  2010-08-11       Impact factor: 3.402

4.  Small invasive colon cancer with systemic metastasis: a case report.

Authors:  Minori Matsumoto; Takeshi Nakajima; Ken Kato; Tsutomu Kouno; Taku Sakamoto; Takahisa Matsuda; Ryoji Kushima; Yutaka Saito
Journal:  BMC Gastroenterol       Date:  2011-05-20       Impact factor: 3.067

5.  Carcinoma of Unknown Primary - an Orphan Disease?

Authors:  Alwin Krämer; Gerdt Hübner; Andreas Schneeweiss; Gunnar Folprecht; Kai Neben
Journal:  Breast Care (Basel)       Date:  2008-06-19       Impact factor: 2.860

Review 6.  FDG PET/CT in carcinoma of unknown primary.

Authors:  Thomas C Kwee; Sandip Basu; Gang Cheng; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10-31       Impact factor: 9.236

7.  Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis.

Authors:  Thomas C Kwee; Robert M Kwee
Journal:  Eur Radiol       Date:  2008-10-17       Impact factor: 5.315

8.  A case of occult intrahepatic cholangiocarcinoma diagnosed by autopsy.

Authors:  Eri Oda; Daisuke Hashimoto; Yuko Shiomi; Koji Ohnishi; Hiromitsu Hayashi; Akira Chikamoto; Motohiro Takeya; Hideo Baba
Journal:  Surg Case Rep       Date:  2015-10-14

9.  Inflammation as a validated prognostic determinant in carcinoma of unknown primary site.

Authors:  Z Mohamed; D J Pinato; F A Mauri; K-W Chen; P M-H Chang; R Sharma
Journal:  Br J Cancer       Date:  2013-10-29       Impact factor: 7.640

10.  Metabolic profiles are principally different between cancers of the liver, pancreas and breast.

Authors:  Anuradha Budhu; Atsushi Terunuma; Geng Zhang; S Perwez Hussain; Stefan Ambs; Xin Wei Wang
Journal:  Int J Biol Sci       Date:  2014-08-30       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.